GGrantIndex
← Search

ASSESSMENT OF MEKK2 AS A NOVEL THERAPEUTIC TARGET IN NEUROFIBROMATOSIS

$169,499FY2016Department of the ArmyDOD

Weill Medical College Of Cornell University

Investigators

View source on USAspending →
ASSESSMENT OF MEKK2 AS A NOVEL THERAPEUTIC TARGET IN NEUROFIBROMATOSIS · GrantIndex